User profiles for Christoph Schindler
 | Christoph SchindlerProfessor der Medizin, Medizinische Hochschule Hannover (MHH) Verified email at mh-hannover.de Cited by 1948 |
Analysis of the exciton-exciton interaction in semiconductor quantum wells
C Schindler, R Zimmermann - Physical Review B, 2008 - APS
The exciton-exciton interaction is investigated for quasi-two-dimensional quantum structures.
A bosonization scheme is applied including the full spin structure. For generating the …
A bosonization scheme is applied including the full spin structure. For generating the …
Clinically and pharmacologically relevant interactions of antidiabetic drugs
M May, C Schindler - Therapeutic advances in endocrinology …, 2016 - journals.sagepub.com
Patients with type 2 diabetes mellitus often require multifactorial pharmacological treatment
due to different comorbidities. An increasing number of concomitantly taken medications …
due to different comorbidities. An increasing number of concomitantly taken medications …
[HTML][HTML] Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial
…, P Mann, A Kroidl, I Leroux-Roels, C Schindler… - Wiener Klinische …, 2021 - Springer
Background We used the RNActive® technology platform (CureVac NV, Tübingen, Germany)
to prepare CVnCoV, a COVID-19 vaccine containing sequence-optimized mRNA coding …
to prepare CVnCoV, a COVID-19 vaccine containing sequence-optimized mRNA coding …
Phase 1 assessment of the safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 in human volunteers
…, A Kroidl, I Leroux-Roels, G Leroux-Roels, C Schindler… - MedRxiv, 2020 - medrxiv.org
There is an urgent need for vaccines to counter the COVID-19 pandemic due to infections
with severe acute respiratory syndrome coronavirus (SARS-CoV-2). Evidence from …
with severe acute respiratory syndrome coronavirus (SARS-CoV-2). Evidence from …
[HTML][HTML] Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy
C Schindler, P Bramlage, W Kirch… - Vascular health and risk …, 2007 - ncbi.nlm.nih.gov
The renin-angiotensin-system (RAS) is a cascade of enzymatic reactions resulting ultimately
in the formation of angiotensin II. Recent research has expanded the knowledge about the …
in the formation of angiotensin II. Recent research has expanded the knowledge about the …
Modern pharmacological treatment of obese patients
M May, C Schindler, S Engeli - Therapeutic advances in …, 2020 - journals.sagepub.com
There are many angles to consider in drug treatment of obese patients. On the one hand,
some specific weight loss drugs are available, on the other, several drugs are associated with …
some specific weight loss drugs are available, on the other, several drugs are associated with …
VPM1002 as prophylaxis against severe respiratory tract infections including coronavirus disease 2019 in the elderly: a phase 3 randomized, double-blind, placebo …
Background Bacille Calmette-Guérin (BCG) vaccination can potentially reduce the rate of
respiratory infections in vulnerable populations. This study evaluates the safety and efficacy of …
respiratory infections in vulnerable populations. This study evaluates the safety and efficacy of …
Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant
…, E Melamed, N Embacher, C Schindler… - Journal of molecular …, 2009 - Springer
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized
by loss of motor neurons in the cerebral cortex, brain stem, and spinal cord. Most cases (…
by loss of motor neurons in the cerebral cortex, brain stem, and spinal cord. Most cases (…
Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12‐Week, Randomized, Controlled Study
…, C Beals, J Ivkovic, H Loft, C Schindler - Movement …, 2021 - Wiley Online Library
Background Modulation of the endocannabinoid system via monoacylglycerol lipase inhibition
with Lu AG06466 (formerly known as ABX‐1431) has previously been shown to reduce …
with Lu AG06466 (formerly known as ABX‐1431) has previously been shown to reduce …
[HTML][HTML] Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and …
…, J Cortés, V Dieras, M May, C Schindler… - Investigational new …, 2018 - Springer
Purpose To investigate the safety and clinical activity of comprehensive human epidermal
growth factor receptor (HER) family receptor inhibition using lumretuzumab (anti-HER3) and …
growth factor receptor (HER) family receptor inhibition using lumretuzumab (anti-HER3) and …